Investment and funding has continued to flow into biotech, unlike most business sectors. But with healthcare and hospital budgets increasingly under pressure, do belt-tightening and consolidation lie ahead? Melanie Senior investigates, with additional reporting by Riku Lähteenmäki.

中文翻译：

---

生物制药异常。

与大多数业务部门不同，投资和资金继续流入生物技术。但是，随着医疗保健和医院预算的压力越来越大，紧缩和整合是否摆在眼前？Melanie Senior进行了调查，RikuLähteenmäki还提供了其他报告。